-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Wave Life Sciences, Lowers Price Target to $18

Benzinga·11/09/2026 15:12:02
B. Riley Securities analyst Madison El-Saadi reiterates Wave Life Sciences (NASDAQ:WVE) with a Buy and lowers the price target from $22 to $18.